Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Small is beautiful in the medical world

Small is beautiful in the medical world. And being able to give European industry the edge in a nearly €200 billion worldwide biomedical market is what drives a consortium of EU-backed partners to make and market smaller, cheaper and better biomedical devices and innovative new applications.

19 Jan 2005

Genomics tools provide clues to what causes 400 million cases of gastrointestinal disease each year

In a study that could benefit medical and food-safety research, scientists have used comparative genomics tools to find clues about why some strains of the bacterium Campylobacter – which each year cause more than 400 million cases of gastrointestinal disease – are more virulent than others.

4 Jan 2005

Chronic users NSAIDs have greater risk of bleeding and visible damage to their small intestine

According to a study published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, chronic users of non-steroidal anti-inflammatory drugs (NSAIDs) have an increased risk of bleeding and visible damage to their small intestine.

4 Jan 2005

Chronic constipation is uncomfortable, but not dangerous

There are a lot of common myths about constipation treatment. An article in the January issue of The American Journal of Gastroenterology dispels those myths and clears numerous misconceptions regarding chronic constipation.

4 Jan 2005

New findings clarify the role of NOD2, a key molecular player in Crohn's Disease

This week, researchers report new findings that clarify the role of NOD2, a key molecular player in Crohn's Disease, in the cellular signaling pathways that control inflammatory responses. NOD2's clinical relevance is clear from the fact that it is encoded by a Crohn's Disease susceptibility gene.

28 Dec 2004

Parasitic worms, or helminths, may be an effective treatment for Crohn's disease

Helminths, such as roundworms and threadworms, are rare in developed countries, where rates of Crohn's disease are high. But in developing countries where corresponding rates of the disease are low, many people carry these parasitic worms.

13 Dec 2004

Association between gastrointestinal disorders and sleep disturbances

Mayo Clinic researchers report in the current issue of Mayo Clinic Proceedings an association between gastrointestinal disorders and sleep disturbances. The association is important because these problems cause significant health issues including greater need for general medical and mental health treatment.

13 Dec 2004

FDA approval of Tysabri, for the treatment of multiple sclerosis

Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.

24 Nov 2004

Urinary incontinence and abdominal pain are key symptoms of ovarian cancer

Results from an Olmsted Medical Center and Mayo Clinic study analyzing symptoms recorded in the medical records of ovarian cancer patients suggest ovarian cancer, long considered asymptomatic until late-stage cancer develops, does in fact have early symptoms, including urinary incontinence and abdominal pain.

18 Nov 2004

Use of the drug etodolac instead of drugs like Celebrex or Bextra could save $40 million annually

People in search of pain relief who take the generic anti-inflammatory etodolac suffer 60 percent fewer gastrointestinal complications than those who take similar drugs, according to researchers at UT Southwestern Medical Center at Dallas and the Dallas Veterans Affairs Medical Center.

14 Nov 2004

Abbott's investigational anti-interleukin-12 fully human monoclonal antibody in Crohn's disease study

Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.

10 Nov 2004

New studies demonstrate efficacy of novel Lipoxin analog in laboratory models of Crohn's disease

Berlex announced today that new laboratory results demonstrate that its modified version of the naturally occurring lipoxin molecule exerts potent anti-inflammatory and immunomodulatory effects in Crohn's disease in vivo models and may provide a promising new oral treatment.

9 Nov 2004

Treatment to control gastroesophageal reflux disease in children found to be ineffective

According to a study published in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, more than 60 percent of the children who received surgical fundoplication to control gastroesophageal reflux disease (GERD) had recurring symptoms of the disease months following surgery.

4 Nov 2004

Analysis shows Remicade reduces pain associated with Crohn's disease

According to a new sub-analysis from the ACCENT I (A Crohn's disease Clinical trial Evaluating infliximab in a New long-term Treatment regimen) trial patients who received a three-dose induction regimen of Remicade experienced a significantly greater reduction in pain as assessed by four different pain questions after ten weeks, compared with patients who received a single dose of Remicade.

2 Nov 2004

New treatment option for patients who have moderately active ulcerative colitis

Results of a study presented today by a Mayo Clinic physician at the 69th Annual Scientific Meeting of the American College of Gastroenterology (ACG) in Orlando, Fla., offer a new treatment option for patients who have moderately active ulcerative colitis.

1 Nov 2004

Pegasys with ribavirin combo may best for reducing hepatitis C viral levels

Interim study results indicate a certain drug combination treatment may suppress the hepatitis C virus more quickly than another.

1 Nov 2004

Symptoms of heartburn and GERD are highly prevalent among obese patients

Overall, heartburn and or acid regurgitation were found among 75 percent of the morbidly obese patients, while 23 percent experienced difficulty swallowing (dysphagia) and 34 percent experienced asthma symptoms.

1 Nov 2004

Infants born to women with Inflammatory Bowel Disease (IBD), no more likely to develop congenital malformations

Infants born to women with Inflammatory Bowel Disease (IBD) are no more likely to develop congenital malformations than infants born to healthy mothers, according to a study presented at the 69th Annual Scientific Meeting of the American College of Gastroenterology.

1 Nov 2004

Esophageal capsule is convenient, safe and sensitive for visualization of esophageal disorders

Researchers in a multi-center pivotal trial of M2Aâ Esophageal Capsule Endoscopy (Given Imaging, Yoqneam, Israel) found that this new technology is comparable to upper GI endoscopy for the detection of severe esophageal problems.

1 Nov 2004

New therapy under development for the treatment of irritable bowel syndrome

A new therapy under development for the treatment of irritable bowel syndrome with diarrhea predominance appears to provide significant improvements in measures of quality of life, according to a study presented at the 69th Annual Meeting of the American College of Gastroenterology.

1 Nov 2004

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Small is beautiful in the medical world

Genomics tools provide clues to what causes 400 million cases of gastrointestinal disease each year

Chronic users NSAIDs have greater risk of bleeding and visible damage to their small intestine

Chronic constipation is uncomfortable, but not dangerous

New findings clarify the role of NOD2, a key molecular player in Crohn's Disease

Parasitic worms, or helminths, may be an effective treatment for Crohn's disease

Association between gastrointestinal disorders and sleep disturbances

FDA approval of Tysabri, for the treatment of multiple sclerosis

Urinary incontinence and abdominal pain are key symptoms of ovarian cancer

Use of the drug etodolac instead of drugs like Celebrex or Bextra could save $40 million annually

Abbott's investigational anti-interleukin-12 fully human monoclonal antibody in Crohn's disease study

New studies demonstrate efficacy of novel Lipoxin analog in laboratory models of Crohn's disease

Treatment to control gastroesophageal reflux disease in children found to be ineffective

Analysis shows Remicade reduces pain associated with Crohn's disease

New treatment option for patients who have moderately active ulcerative colitis

Pegasys with ribavirin combo may best for reducing hepatitis C viral levels

Symptoms of heartburn and GERD are highly prevalent among obese patients

Infants born to women with Inflammatory Bowel Disease (IBD), no more likely to develop congenital malformations

Esophageal capsule is convenient, safe and sensitive for visualization of esophageal disorders

New therapy under development for the treatment of irritable bowel syndrome

Microbiology eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Microbiology eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in